Early-stage funding for European life sciences companies, focusing on biotech, medtech, and diagnostics that demonstrate scientific innovation, unmet medical need, and proof of concept.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Europe
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
Netherlands
28.0%United States of America
20.0%Germany
12.0%United Kingdom
12.0%Belgium
4.0%Other
4.0%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
No stages listed
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Fund V
Vintage 2023 • $165.0M
Fund IV
Vintage 2020 • $154.0M